We are live on ! Find out more
Ameriprise

Ameriprise Portfolio holdings

AUM $432B
1-Year Est. Return 30.22%
 

Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.

This Fund
S&P 500
This Quarter Est. Return
+6.73%
1 Year Est. Return
+30.22%
3 Year Est. Return
+89.37%
5 Year Est. Return
+112.58%
10 Year Est. Return
+443.56%
AUM
$286B
AUM Growth
+$60.1B
Cap. Flow
-$3.27B
Cap. Flow %
-1.14%
Top 10 Hldgs %
14.64%
Holding
3,869
New
237
Increased
1,955
Reduced
1,434
Closed
137

Sector Composition

Rank Sector Weight
1 Technology 15.6%
2 Financials 12.74%
3 Healthcare 11.15%
4 Industrials 7.88%
5 Consumer Discretionary 7.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SFUN
3551
DELISTED
Fang Holdings Limited American Depositary Shares (each representing ten Class A Ordinary Shares)
SFUN
$87K ﹤0.01%
+676
New +$103K
SMI
3552
DELISTED
Semiconductor Manufacturing Intl
SMI
$87K ﹤0.01%
15,929
-1,095
-6% -$6.4K
JYNT icon
3553
The Joint Corp
JYNT
$118M
$86K ﹤0.01%
10,000
SRNE
3554
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$85K ﹤0.01%
19,330
-200
-1% -$1.11K
UMC icon
3555
United Microelectronic
UMC
$47.7B
$83K ﹤0.01%
32,126
+4,901
+18% +$13.4K
VATE icon
3556
INNOVATE Corp
VATE
$111M
$83K ﹤0.01%
1,365
XXII
3557
22nd Century Group
XXII
$1.38M
0
BLCM
3558
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$80K ﹤0.01%
1,313
+7
+0.5% +$474
PSXP
3559
DELISTED
PHILLIPS 66 PARTNERS LP
PSXP
$80K ﹤0.01%
+1,559
New +$81.4K
SDR
3560
DELISTED
SANDRIDGE MISSISSIPPIAN TRUST II
SDR
$78K ﹤0.01%
60,460
+31,988
+112% +$50K
PACB icon
3561
Pacific Biosciences
PACB
$435M
$76K ﹤0.01%
12,992
-3,000
-19% -$12.9K
SBS icon
3562
Sabesp
SBS
$19.1B
$75K ﹤0.01%
65,472
-125,716
-66% -$153K
AGTC
3563
DELISTED
Applied Genetic Technologies Corporation
AGTC
$74K ﹤0.01%
10,128
CFMS
3564
DELISTED
Conformis, Inc. Common Stock
CFMS
$73K ﹤0.01%
2,723
+400
+17% +$10.9K
BLDP
3565
Ballard Power Systems
BLDP
$805M
$70K ﹤0.01%
+16,171
New +$53.5K
TEN
3566
Tsakos Energy Navigation Ltd
TEN
$1.21B
$70K ﹤0.01%
4,140
-1,512
-27% -$25.9K
TTPH
3567
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$68K ﹤0.01%
1,225
+50
+4% +$3.19K
SBSW icon
3568
Sibanye-Stillwater
SBSW
$6.26B
$67K ﹤0.01%
+26,724
New +$64.2K
ANH
3569
DELISTED
Anworth Mortgage Asset Corporation
ANH
$67K ﹤0.01%
14,423
-2,911
-17% -$14.3K
INO icon
3570
Inovio Pharmaceuticals
INO
$55.7M
$66K ﹤0.01%
988
-791
-44% -$44K
CALA
3571
DELISTED
Calithera Biosciences, Inc
CALA
$66K ﹤0.01%
635
-127
-17% -$12.1K
NAGE
3572
Niagen Bioscience
NAGE
$271M
$64K ﹤0.01%
14,827
+500
+3% +$2.15K
OPCH icon
3573
Option Care Health
OPCH
$3.45B
$62K ﹤0.01%
5,030
FNDA icon
3574
Schwab Fundamental US Small Company Index ETF
FNDA
$9.12B
$58K ﹤0.01%
+2,838
New +$58.1K
SUNE
3575
SUNation Energy
SUNE
$8.95M
0

Similar funds

Ameriprise's Q3 2018 Portfolio in Review

As of Q3 2018, Ameriprise held 3,869 positions worth $286B, up 27% from $226B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Ameriprise's Q3 2018 filing shows 237 new, 1,955 increased, 1,434 reduced and 137 closed positions. Its largest new stake was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 55,160 shares worth $58.8M. The largest sale was Applied Materials, an estimated $397M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.

  • Ameriprise's largest Q3 2018 buy was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 55,160 shares worth $58.8M.
  • Ameriprise added most to Lockheed Martin in Q3 2018, an estimated $327M increase.
  • Ameriprise's biggest Q3 2018 reduction was Applied Materials, cutting an estimated $397M.
  • Ameriprise fully exited Cavium, Inc. in Q3 2018, selling an estimated $172M.
  • Ameriprise's ten largest holdings make up 15% of its $286B portfolio in Q3 2018.
  • Ameriprise opened 237 new positions and closed 137 in Q3 2018.
  • Ameriprise's portfolio value rose 27% quarter-over-quarter to $286B.

Based on Ameriprise's 13F filing for Q3 2018, filed 14 Nov 2018.